Skip to main content
. 2017 Aug 29;17:584. doi: 10.1186/s12885-017-3577-x

Fig. 3.

Fig. 3

The prognostic power of a panel consisting of potentially four favorable prognostic markers, including high expression of CD8+ T-cells and FOXP3+ T-cells, low tumor expression of Ki67 and BRAF wildtype status is demonstrated. A highly significant increase in the proportion of long-term survivors in association with the increase from one to four favorable markers (Logistic regression, p = 0.003)